Impact of ledipasvir/sofosbuvir on the work productivity of genotype 1 chronic hepatitis C patients in Asia.
Outcome comparison of liver transplantation for hepatitis A-related versus hepatitis B-related acute liver failure in adult recipients.
Performing Gadoxetic Acid-Enhanced MRI After CT for Guiding Curative Treatment of Early-Stage Hepatocellular Carcinoma: A Cost-Effectiveness Analysis.
Poor adherence to hepatocellular carcinoma surveillance: A systematic review and meta-analysis of a complex issue.
Response to: 'Prognosis of immune-tolerant phase chronic hepatitis B' by Chu and Liaw.
Stereotactic body radiation therapy using a respiratory-gated volumetric-modulated arc therapy technique for small hepatocellular carcinoma
Association between non-alcoholic fatty liver disease and cancer incidence rate.
Characteristics, Prevention, and Management of Hepatitis B Virus (HBV) Reactivation in HBV-Infected Patients Who Require Immunosuppressive Therapy.
Clinical features and outcomes of patients with hepatocellular carcinoma complicated with bile duct invasion.
Clinical impact of preoperative brain MR angiography and MR imaging in candidates for liver transplantation: a propensity score-matching study in a single institution
Clinical validity of Metroticket calculator in transplant patients undergoing prior chemoembolization for hepatocellular carcinoma.
Daclatasvir/asunaprevir/beclabuvir, all-oral, fixed-dose combination for patients with chronic hepatitis C virus genotype 1.
Efficacy and safety of entecavir versus lamivudine over 5 years of treatment: A randomized controlled trial in Korean patients with hepatitis B e antigen-negative chronic hepatitis B.
Genetic-based Risk Assessment for Hepatocellular Carcinoma in Patients with Hepatitis C: Where Do We Stand?
High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B.
Impact of emergency adult living donor liver transplantation on the survival of patients with antituberculosis therapy-induced acute liver failure.
Increasing burden of liver cancer despite extensive use of antiviral agents in a hepatitis B virus-endemic population.
Lamivudine: fading into the mists of time.
Management of Antiviral Resistance in Chronic Hepatitis B.
New intermediate-stage subclassification for patients with hepatocellular carcinoma treated with transarterial chemoembolization.
Prognostic Implication of Inflammation-based Prognostic Scores in Patients with Intrahepatic Cholangiocarcinoma Treated with First-line Gemcitabine plus Cisplatin.
Prognostic Scoring Models for Patients Undergoing Sorafenib Treatment for Advanced Stage Hepatocellular Carcinoma in Real-Life Practice.
Role of Computed Tomography Volumetry in Estimating Liver Weights in Surgical Patients with Hepatic Steatosis.
Telbivudine versus entecavir in patients with undetectable hepatitis B virus DNA: a randomized trial.
The effect of interferon-free regimens on health-related quality of life in East Asian patients with chronic hepatitis C.
Tumor Volume Doubling Time as a Dynamic Prognostic Marker for Patients with Hepatocellular Carcinoma.
A phase 3b study of sofosbuvir plus ribavirin in treatment-naive and treatment-experienced Korean patients chronically infected with genotype 2 hepatitis C virus.
A phase IIIb study of ledipasvir/sofosbuvir fixed-dose combination tablet in treatment-na?ve and treatment-experienced Korean patients chronically infected with genotype 1 hepatitis C virus.
A phase IIIb study of ledipasvir/sofosbuvir fixed-dose combination tablet in treatment-na?ve and treatment-experienced Korean patients chronically infected with genotype 1 hepatitis C virus.
All-oral daclatasvir plus asunaprevir for chronic HCV genotype 1b infection: a sub-analysis in Asian patients from the HALLMARK DUAL study.
Apoptosis of Hepatitis B Virus-expressing Liver Tumor Cells Induced by a High Concentration of Nucleos(t)ide Analogue.
Clinical Characteristics and Treatment Outcome of Peginterferon Plus Ribavirin in Patients Infected with Genotype 6 Hepatitis C Virus in Korea: A Multicenter Study.
Clinical Features and Outcomes of Spontaneous Bacterial Peritonitis Caused by Streptococcus pneumoniae: A Matched Case?Control Study
Clinical characteristics and potential etiologies of non-B non-C hepatocellular carcinoma in hepatitis B virus endemic areas.
Comprehensive outcomes of on- and off-antiviral prophylaxis in hepatitis B patients undergoing cancer chemotherapy: A competing risks analysis.
Diagnostic criteria for hepatocellular carcinoma 3 cm with hepatocyte-specific contrast-enhanced magnetic resonance imaging
Erratum to: Clinical characteristics and outcomes of spontaneous bacterial peritonitis caused by Enterobacter species versus Escherichia coli: a matched case-control study.
MRI With Liver-Specific Contrast for Surveillance of Patients With Cirrhosis at High Risk of Hepatocellular Carcinoma.
Process Innovation Improves Trial Operation Efficiency.
Role of transarterial chemoembolization in relation with sorafenib for patients with advanced hepatocellular carcinoma.
The impact of hepatitis C virus outside the liver: Evidence from Asia.
Validation and reappraisal of the assessment for retreatment with transarterial chemoembolization score for unresectable non-metastatic hepatocellular carcinoma in a hepatitis b virus-endemic region.
A Patient-Based Nomogram for Predicting Overall Survival after Radiofrequency Ablation for Hepatocellular Carcinoma.
Absence of Benefit of Transcatheter Arterial Chemoembolization (TACE) in Patients with Resectable Solitary Hepatocellular Carcinoma.
Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma.
Alpha-fetoprotein normalization as a prognostic surrogate in small hepatocellular carcinoma after stereotactic body radiotherapy: a propensity score matching analysis.
Comparison of Chemoembolization with and without Radiation Therapy and Sorafenib for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Propensity Score Analysis
Comparison of chemoembolization with and without radiation therapy and sorafenib for advanced hepatocellular carcinoma with portal vein tumor thrombosis: a propensity score analysis.
Evaluation of Early-stage Hepatocellular Carcinoma by Magnetic Resonance Imaging with Gadoxetic Acid Detects Additional Lesions and Increases Overall Survival
Fibroblast growth factor receptor isotype expression and its association with overall survival in patients with hepatocellular carcinoma
Initial human experience of endoscopic ultrasound-guided photodynamic therapy with a novel photosensitizer and a flexible laser-light catheter.
Intimate association of visceral obesity with non-alcoholic fatty liver disease in healthy Asians: A case-control study.
Nomograms for Predicting Outcomes after Chemoembolization in Patients with Nonmetastatic Hepatocellular Carcinoma.
Propensity Score Matching Analysis of Changes in Alpha-Fetoprotein Levels after Combined Radiotherapy and Transarterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.
Response to Letter Regarding Article, "Prevalence and Prediction of Coronary Artery Disease in Patients With Liver Cirrhosis: A Registry-Based Matched Case-Control Study".
Risk prediction for patients with hepatocellular carcinoma undergoing chemoembolization: development of a prediction model.
Tenofovir monotherapy versus tenofovir and entecavir combination therapy in adefovir-resistant chronic hepatitis B patients with multiple drug failure: results of a randomised trial.
Tenofovir monotherapy versus tenofovir and entecavir combination therapy in patients with entecavir-resistant chronic hepatitis B with multiple drug failure: results of a randomised trial.
The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection.
Clinical features, image findings, and prognosis of inflammatory pseudotumor of the liver: a multicenter experience of 45 cases.
Clinical implications of preoperative and intraoperative liver biopsies for evaluating donor steatosis in living related liver transplantation.
Clinical significance of the best response during repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma.
Clinicobiochemical prediction of biopsy-proven cases of severe hepatic fibrosis in patients with chronic hepatitis C infection
Determination of normal hepatic elasticity by using real-time shear-wave elastography.
HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability
Hepatoid differentiation in renal cell carcinoma: a rare histologic pattern with clinical significance.
Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: A need for surveillance
Mortality, liver transplantation, and hepatocellular carcinoma among patients with chronic hepatitis B treated with entecavir vs lamivudine.
Optimal methods for measuring eligibility for liver transplant in hepatocellular carcinoma patients undergoing transarterial chemoembolization
Prevalence and prediction of coronary artery disease in patients with liver cirrhosis: a registry-based matched case-control study.
Prognostic nomograms for prediction of recurrence and survival after curative liver resection for hepatocellular carcinoma.
Prognostic performance of preoperative gadoxetic acid-enhanced MRI in resectable hepatocellular carcinoma.
Reappraisal of serum alpha-foetoprotein as a surveillance test for hepatocellular carcinoma during entecavir treatment
Role of 15-hydroxyprostaglandin dehydrogenase down-regulation on the prognosis of hepatocellular carcinoma
(4S)-4-(3-18F-Fluoropropyl)-L-Glutamate for Imaging of xC Transporter Activity in Hepatocellular Carcinoma Using PET: Preclinical and Exploratory Clinical Studies.
Clinical Implications of Arrest-Defective Protein 1 Expression in Hepatocellular Carcinoma: A Novel Predictor of Microvascular Invasion
Clinical courses of chronic hepatitis B virus infection and inflammatory bowel disease in patients with both diseases.
Clinical features of adult patients with secondary hemophagocytic lymphohistiocytosis from causes other than lymphoma: an analysis of treatment outcome and prognostic factors
Clinical utility of des-γ-carboxyprothrombin kinetics as a complement to radiologic response in patients with hepatocellular carcinoma undergoing transarterial chemoembolization
Colorectal neoplasms in relation to non-alcoholic fatty liver disease in Korean women: a retrospective cohort study.
Effect of Response to Interferon-alpha Therapy on the Occurrence of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
Entecavir plus Adefovir Combination Treatment for Chronic Hepatitis B Patients after Failure of Nucleos(t)ide Analogues
Entecavir plus Adefovir in Lamivudine-Resistant Chronic Hepatitis B Patients with suboptimal Response to Lamivudine plus Adefovir : A Randomized Trial.
Exercise and diet modification in non-obese non-alcoholic fatty liver disease: Analysis of biopsies of living liver donors
Half-Life of Serum Alpha-Fetoprotein: An Early Prognostic Index of Recurrence and Survival After Hepatic Resection for Hepatocellular Carcinoma.
High HBV-DNA Titer in Surrounding Liver Rather Than in Hepatocellular Carcinoma Tissue Predisposes to Recurrence After Curative Surgical Resection
Is serum alpha-fetoprotein useful for predicting recurrence and mortality specific to hepatocellular carcinoma after hepatectomy? A test based on propensity scores and competing risks analysis
Maximum number of target lesions required to measure responses to transarterial chemoembolization using the enhancement criteria in patients with intrahepatic hepatocellular carcinoma
Multiplex polymerase chain reaction test for the diagnosis of acute viral hepatitis A
Practical approach to endoscopic management for bleeding gastric varices.
 Predicting survival after living and deceased donor liver transplantation in adult patients with acute liver failure.
Radiotherapy Plus Transarterial Chemoembolization for Hepatocellular Carcinoma Invading the Portal Vein: Long-Term Patient Outcomes
Randomized Trial of Entecavir plus Adefovir in Patients with Lamivudine-Resistant Chronic Hepatitis B Who Show Suboptimal Response to Lamivudine plus Adefovir
Role of the routine use of chest computed tomography and bone scan in staging workup of hepatocellular carcinoma
Sorafenib Dose Escalation in the Treatment of Advanced Hepatocellular Carcinoma
Which response criteria best help predict survival of patients with hepatocellular caricnoma following chemoembolization? A validation study of old and new models.
rtL180M mutation of hepatitis B virus is closely associated with frequent virological resistance to adefovir dipivoxil therapy
Transforming Growth Factor Beta 1 Overexpression Is Closely Related to Invasiveness of Hepatocellular Carcinoma
Applicability of the BCLC staging system to patients with hepatocellular carcinoma in Korea: analysis at a single center with a liver transplant center.
Clinical outcome of 251 patients with extrahepatic metastasis at initial diagnosis of hepatocellular carcinoma: does transarterial chemoembolization improve survival in these patients?
Could HBx Protein Expression Affect Signal Pathway Inhibition by Gefitinib or Selumetinib, a MEK Inhibitor, in Hepatocellular Carcinoma Cell Lines?
Focal Nodular Hyperplasia or Focal Nodular Hyperplasia-like Lesions of the Liver: A Special Emphasis on Diagnosis.
Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma.
간경변증 환자의 수술 후 사망률 평가: Child에서 MELD로의 성장
Combination of transarterial chemoembolization and three-dimensional conformal radiotherapy for hepatocellular carcinoma with inferior vena cava tumor thrombus.
Donor Race Does not Predict Graft Failure after Liver Transplantation.
Efficacy of entecavir in treatment-naïve patients with hepatitis B virus-related decompensated cirrhosis.
Emergency adult-to-adult living-donor liver transplantation for acute liver failure in a hepatitis B virus-endemic area.
Estimation of the healthy upper limits for serum alanine aminotransferase in Asian populations with normal liver histology.
Lamivudine plus adefovir or entecavir for patients with chronic hepatitis b resistant to lamivudine and adefovir.
Serum Sodium, Renal Function and Survival of Patients with End-Stage Liver Disease.
급성 간부전: 원인, 예후, 치료
중증 간질환을 동반한 적혈구조혈성 포르피린증 환자에서의 cholestyramine 치료: 사례보고
C형간염바이러스 유전자형 1b에 감염된 한국인 환자에서 인터페론 감수성 결정 영역의 유전자 돌연변이 양상
Complete Necrosis After Transarterial Chemoembolization Could Predict Prolonged Survival in Patients with Recurrent Intrahepatic Hepatocellular Carcinoma After Curative Resection.
Continuous peritransplant assessment of consciousness using bispectral index monitoring for patients with fulminant hepatic failure undergoing urgent liver transplantation.
Efficacy and safety of 3-year adefovir dipivoxil treatment in Korean patients with HBeAg-positive chronic hepatitis B
Hepatitis B virus with the rtL80V/I mutation is associated with a poor response to adefovir dipivoxil therapy.
Surgical Treatments and Prognoses of Patients with Combined Hepatocellular Carcinoma and Cholangiocarcinoma
Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome.
Prevention of hepatitis B recurrence after living donor liver transplantation: primary high-dose hepatitis B immunoglobulin monotherapy and rescue antiviral therapy
Susceptibility to type 1 autoimmune hepatitis is associated with shared amino acid sequences at positions 70-74 of the HLA-DRB1 molecule.
특발성 비신단락을 동반한 간경변증 환자의 간성 척수병증 2예
Biochemical Rather than Virologic Response to Interferon Therapy may be More Closely Associated with Decrease of Hepatocellular Carcinoma Incidence in Patients with Chronic Hepatitis B
Diagnosis of hepatic steatosis and fibrosis by transient elastography in asymptomatic healthy individuals: a prospective study of living related potential liver donors.
Hepatitis B reactivation during adjuvant anthracycline-based chemotherapy in patients with breast cancer: A single institution’s experience
Increased risk of adeforvir resistance in patients with lamivudine-resistant chronic heapatitis B after 48 weeks of adfovir dipivoxil monotherapy
Preoperative portal vein embolization and surgical resection in patients with hepatocellular carcinoma and small future liver remnant volume: comparison with transarterial chemoembolization.
Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center.
진행된 간세포암에서의 간문맥 혈전증에 대한 방사선치료 효과
Association of specific amino acid sequence of HLA-DR with autoimmune hepatitis
Clinical Features And Outcomes of Hepatic Failure Assoiciated with Epstein-Barr Virus lnfection
Clinical Features And Outcomes of Severe Epstein-Barr Virus Hepatitis Presented with Jaundice
Clinical Features of Fulminant Hepatic Failure in a Tertiary Hospital with a Liver Transplant Center in Korea
Increased risk of adefovir resistance in patients with Iamivudine-resistant chronic hepatitis B after 48 weeks of adfovir dipivoxil monotherapy
Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy.
Nine Cases of Sporadic Acute Hepatitis E in Korea
Safety and Efficacy of Three-Dimensional Conformal Radiotherapy for Portal Vein Tumor Thrombus by Hepatocellular Carcinoma
위정맥류 출혈의 내시경적 지혈술
A형 간염 바이러스에 의한 전격성 간부전 5예의 임상 경과
특발성 문맥압 항진증 8예의 임상 및 병리학적 분석
간세포암의 문맥 침범에 대한 방사선치료의 효과와 안전성
간세포암의 하대정맥 침범에 대한 방사선치료의 효과
A case of nizatidine induced cholestatic hepatitis.
Adefovir dipivoxil alone or in combination with ongoning lamivudine in patients with decompensated liver disease and lamivudine-resistant hepatitis B virus
Prediction of treatment outcome in chronic hepatitis C patients based on early viral dynamics during high-dose induction interferon and ribavirin therapy.
The effect of preoperative transarterial chemoembolization on the patient's outcome in resectable hepatocellular carcinoma.
Usefulness of reagent strips for the diagnosis of spontaneous bacterial peritonitis.
한국 성인 자가 면역성 간염 환자들에서 감수성 조직적합항원(HLA) 분석
최근 3년간 급성 바이러스성 간염의 원인 분석
전격성 간부전의 원인, 임상양상, 사망예견인자
절제가능한 간세포암에서 수술 전 경동맥화학색전술의 효과
Current antiviral therapy for chronic hepatitis B.
Role of additional angiography and chemoembolization in patients with hepatocellular carcinoma who achieved complete necrosis following transarterial chemoembolization.
Quantitative polymerase chain reaction assay for serum hepatitis B virus DNA as a predictive factor for post-treatment relapse after lamivudine induced hepatitis B e antigen loss or seroconversion.

암에 대한 모든 것 (가림건강신서 54)